AET,UPDATE 1-Judge sets Aetna-Humana antitrust trial date for Dec. 5 Washington DC, Aug 10 The federal judge hearing the U.S. Justice Department's case to block Aetna Inc's  $34 billion purchase of Humana Inc has set a trial date for Dec. 5, later than the companies had requested. ~Judge sets Aetna-Humana antitrust trial date for December 5 Washington DC The U.S. District Court judge hearing the U.S. Justice Department's case to block Aetna Inc.'s  $34 billion purchase of Humana Inc.  has set a trial date for Dec. 5, 2016, later than the companies had requested. ~
AMZN.O,UPDATE 1-China's JD.com revenue meets expectations as slowdown set to continue BEIJING, Aug 10 JD.com Inc, China's second biggest e-commerce company, reported revenue for the second quarter of 2016 that was within company forecasts, even as the growth rate continued a steady decline that is expected to continue. ~
BAC,HSBC, BofA apply blockchain to trade finance, seek more partners HONG KONG, Aug 10 HSBC  and Bank of America Merrill Lynch said on Wednesday they had created the world's first application using blockchain technology to simplify one of the most cumbersome aspects of trade finance. ~
BRKa.N,BRIEF-Berkshire Hathaway Finance Corp to offer $1 bln of its 1.300 pct senior notes - SEC filing * Berkshire Hathaway Finance Corp files to offer $1 bln of its 1.300 pct senior notes due 2019 and $250 mln of its floating rate senior notes due 2019 - SEC filing  Source: (http://bit.ly/2bh7hJY ) Further company coverage: ~
BA,UPDATE 3-Boeing will not raise 787 production unless market demands it NEW YORK, Aug 10 Boeing Co said on Wednesday it will not increase 787 output and could further cut 777 output unless sales of both jets improve, its clearest indication yet that its production of large jetliners may have peaked for now. ~Boeing may not raise 787 production to 14 a month, will follow market -CFO NEW YORK, Aug 10 Boeing Co may not raise production of its 787 Dreamliner  jet to 14 a month but will generate more cash even if it does not lift output from the current rate of 12 a month, Chief Financial Officer Greg Smith said on Wednesday. ~
CHK,Chesapeake to sell interests in Barnett shale operating area Aug 10 Chesapeake Energy Corp said on Wednesday it agreed to sell its interests in the Barnett shale operating area to private equity-backed Saddle Barnett Resources LLC. ~
DAL,Refiners on track to spend record on U.S. clean fuel standards NEW YORK, Aug 10 Major refiners like Valero Energy Corp are on track to pay record amounts this year for credits to comply with U.S. renewable fuel rules, corporate filings show, a trend that hurts profits and has some looking to export more to avoid the cost. ~UPDATE 3-Delta cancels hundreds more flights, expects normal operations soon Aug 10 Delta Air Lines Inc on Wednesday canceled more than 300 flights and upended thousands of travelers' plans for the third day in a row after a power outage hit its computer systems, though it forecast a return to normal operations later this afternoon. ~Delta expects normal operations to resume on Wednesday Aug 10 Delta Air Lines said it expects to return to normal operations on Wednesday after a power outage hit its computer systems on Monday, causing the cancellation of more than 1,600 flights over two days. ~BRIEF-Delta Air Lines says outlook for Wednesday's operation is positive * Delta Air Lines says "working hard to achieve a normal operation by mid day tomorrow" ~
HUM,UPDATE 1-Judge sets Aetna-Humana antitrust trial date for Dec. 5 Washington DC, Aug 10 The federal judge hearing the U.S. Justice Department's case to block Aetna Inc's  $34 billion purchase of Humana Inc has set a trial date for Dec. 5, later than the companies had requested. ~Judge sets Aetna-Humana antitrust trial date for December 5 Washington DC The U.S. District Court judge hearing the U.S. Justice Department's case to block Aetna Inc.'s  $34 billion purchase of Humana Inc.  has set a trial date for Dec. 5, 2016, later than the companies had requested. ~
LLY,Lilly breast cancer drug stumbles, but trial continues U.S. drugmaker Eli Lilly and Co on Wednesday said it would continue a late-stage trial of its experimental breast cancer drug in combination with a widely used treatment even though an independent panel determined the combination therapy failed to meet its interim effectiveness goal. ~Panel recommends Lilly continue breast cancer drug study Aug 10 Eli Lilly and Co said an interim analysis of a late-stage study testing its breast cancer drug abemaciclib by an independent panel showed the treatment did not meet the effectiveness criteria and recommended that the company continue the trial. ~
KORS.N,UPDATE 4-Michael Kors comparable sales drop more than expected * To further reduce promotions next year - CEO   (Adds details, CEO comments; updates shares) ~BRIEF-Michael Kors to further reduce promotional activity, starting Q1 next year - executive * Michael Kors Executive - Capital expenditures expected to total about $250 million for fiscal 2017 - conf call ~BRIEF-Michael Kors Q1 EPS $0.88 excluding items * Sees FY 2017 non-GAAP earnings per share $4.56 to $4.64 excluding items ~Michael Kors comparable store sales drop more than expected Aug 10 Michael Kors Holdings Ltd  reported a bigger-than-expected drop in quarterly comparable store sales, hurt by lower mall traffic and reduced tourist spending. ~
MUR,BRIEF-Murphy Oil Corp announces intent to enter into new credit facility * Murphy Oil Corp announces intent to enter into new credit facility ~
PRGO.N,Perrigo slashes full-year forecast again, shares plunge Aug 10 Perrigo Co Plc slashed its full-year earnings forecast for the second time, citing pricing pressure in its generic drugs business, sending its shares down as much as 13 percent and wiping out about $1.77 billion of market value. ~
PFE,N.Y. investment adviser, lawyer indicted for insider trading NEW YORK A Long Island investment adviser and a former partner at a major law firm have been indicted on charges that they engaged in insider trading ahead of Pfizer Inc's acquisition of King Pharmaceuticals Inc in 2010, prosecutors said on Wednesday. ~
LUV,UPDATE 1-Southwest Air forecasts further drop in current-qtr unit revenue Aug 10 Southwest Airlines Co forecast a further drop in a key profitability metric for the current quarter due to delays and cancellations of more than 2,000 flights after an outage hit its computer systems in July. ~BRIEF-Southwest Airlines reports July traffic * July 2016 load factor was 86.9 percent, compared with 87.7 percent in july 2015. ~Southwest Airlines forecasts further drop in unit revenue Aug 10 Southwest Airlines Co forecast a further drop in a key profitability metric for the current quarter due to delays and cancellations of more than 2,000 flights after an outage hit its computer systems in July. ~
UNH,Fitch Affirms UnitedHealth Group; Outlook Remains Negative (The following statement was released by the rating agency) CHICAGO, August 10 (Fitch) Fitch Ratings has affirmed UnitedHealth Group  Incorporated's (UNH) Issuer Default Rating (IDR) at 'A' and its senior unsecured  notes at 'A-'. Fitch has also affirmed the 'AA-' Insurer Financial Strength  ratings of UNH's insurance company subsidiaries. The Rating Outlook remains  Negative. A complete list of rating actions follows at the end of this release. KEY RATING DRIVERS  The affirmation of UNH's ratin ~
WMT,UPDATE 3-Wal-Mart's Mexico unit selling apparel chain for about $852 mln CHICAGO, Aug 10 Wal-Mart Stores Inc's  Mexican unit said on Wednesday it has agreed to sell its Suburbia clothing chain to El Puerto De Liverpool  for about $852 million as the world's largest retailer streamlines operations in its largest non-U.S. market. ~
YUM,CORRECTED-UPDATE 1-Consumer groups press Yum's KFC to tighten antibiotic rules LOS ANGELES, Aug 10 Consumer groups will deliver a petition from more than 350,000 people to the KFC restaurant chain on Wednesday, calling on the Yum Brands Inc unit  to stop the routine use of antibiotics by the companies that supply its chicken. ~Cargill stops using human antibiotic to prevent disease in turkeys CHICAGO U.S. meat processor Cargill Inc [CARG.UL] has stopped using an important antibiotic for people to prevent disease in most of its turkeys, the company said on Tuesday, the latest food maker to drop the drug over concerns about the impact on human medicine. ~UPDATE 1-Cargill stops using human antibiotic to prevent disease in turkeys CHICAGO, Aug 9 U.S. meat processor Cargill Inc  has stopped using an important antibiotic for people to prevent disease in most of its turkeys, the company said on Tuesday, the latest food maker to drop the drug over concerns about the impact on human medicine. ~
